Sorrento Therapeutics, Inc. aka SRNE

SRNE Current Situation

  • Hold Stock and it has an estimated open position change of 84.93%

SRNE Plot with Buy and Sell Trade Signals

  • SRNE open price graphed for last 12 months
    • Rolling 12 month plot starts on 2020-02-03
    • Rolling 12 month only includes complete buy sell pairs
    • Rolling 12 month does’t include open positions
  • Buy is marked with an X
  • Sell is marked with an octagon
  • Trades are executed at market open
  • A buy and a sell resulting in a gain is highlighted in green
  • A buy and a sell resulting in a loss is highlighted in red
  • Click any graph below to view it full screen


Adjusted Open Plot for Sorrento Therapeutics, Inc. (SRNE)

Cumulative Trading Results for Sorrento Therapeutics, Inc. (SRNE)

Cumulative Benchmark Buy and Hold Results for Sorrento Therapeutics, Inc. (SRNE)

SRNE Closed Position Trading Results

Total Percentage Period
19.19 3 Months
29.64 6 Months
164.82 9 Months
0.00 YTD Months
111.93 12 Months
311.00 24 Months
297.22 All Months

SRNE 12 Month Return Comparison

Total Percentage Strategy
111.93 FonzAI System Closed Positions
84.93 FonzAI Open Position
262.37 Buy and Hold Benchmark
-65.51 FonzAI Excess Return

SRNE 12 Month Extrema Comparison

Max Drawdown Max High-water Strategy
-52.90 196.86 FonzAI System Open and Closed Positions
-56.47 376.32 Buy and Hold Benchmark
3.57 -179.46 FonzAI Extrema Delta

FonzAI System Goals

  • Make profitable trades
  • Minimize losses
  • Achieve less max drawdown than benchmark
  • Protect users by eliminating investments with low liquidity
  • Protect users by eliminating investments with high volatility

Trade Assumptions

  • Results are added up to calculate total % change
  • Results don’t account for compounding of % gains
  • Results that are positive are gains
  • Results that are negative are losses
  • Results don’t include incomplete buy/sell pairs (e.g. a buy without a sell)
  • Results don’t account for dividends, even if dividend payment is applicable
  • Results include a commission of $0.029 per share for both buys and sells
  • You need to account for your broker’s commission costs if applicable
  • Results may be impacted by inaccurate or incomplete data
  • Results are only for educational and informational use
  • Results don’t account for taxes
  • You need to consult a tax professional
  • Buy and hold strategy for SRNE was used as the benchmark
  • Click on video below to see trade signals over time
  • Click on video full screen button (box with corners) for easy viewing
Leave a Reply